Suppression of Peroxiredoxin 4 in Glioblastoma Cells Increases Apoptosis and Reduces Tumor Growth

• Tae Hyong Kim,

  Affiliations Dardinger Center for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America, Solid Tumor Program, The James Comprehensive Cancer Center, the Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯
• Jieun Song,

  Affiliations Dardinger Center for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America, Solid Tumor Program, The James Comprehensive Cancer Center, the Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯
• Sheila R. Alcantara Llaguno,

  Affiliation Department of Developmental Biology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Eric Murnan,

  Affiliations Dardinger Center for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America, Solid Tumor Program, The James Comprehensive Cancer Center, the Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯
• Sandya Liyanarachchi,

  Affiliation Human Cancer Genetics Program and Biomedical Informatics Shared Resources, The James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯
• Kamalakannan Palanichamy,

  Affiliation Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯
• Ji-Yeun Yi,

  Affiliations Dardinger Center for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America, Solid Tumor Program, The James Comprehensive Cancer Center, the Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯
• Mariano Sebastian Viapiano,

  Affiliation Dardinger Center for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯
• Ichiro Nakano,

  Affiliation Dardinger Center for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯
• Sung Ok Yoon,

  Affiliation Department of Molecular and Cellular Biochemistry and the James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯
• Hong Wu,

  Affiliation Department of Molecular and Medical Pharmacology and Institute for Molecular Medicine, School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Luis F. Parada,

  Affiliation Department of Developmental Biology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Chang-Hyuk Kwon

  * E-mail: Chang-Hyuk.Kwon@osumc.edu

  Affiliations Dardinger Center for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America, Solid Tumor Program, The James Comprehensive Cancer Center, the Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America

  ⨯